We are live on
!
Find out more
HRCM
Hood River Capital Management Portfolio holdings
AUM
$9.98B
1-Year Est. Return
145.42%
This Fund
S&P 500
This Quarter
Est. Return
+59.49%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$2.23B
AUM Growth
+$481M
(+27%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-5.05%
Top 10 Holdings %
Top 10 Hldgs %
28.48%
Holding
136
New
38
Increased
24
Reduced
39
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$34M |
| 2 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$30.4M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$29.9M |
| 4 |
Stride
LRN
|
+$27.7M |
| 5 |
APi Group
APG
|
+$27.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$76.6M |
| 2 |
Kinsale Capital Group
KNSL
|
+$39.1M |
| 3 |
Cogent Communications
CCOI
|
+$32.9M |
| 4 |
PDM
Piedmont Realty Trust
PDM
|
+$29.2M |
| 5 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.79% |
| 2 | Technology | 22.2% |
| 3 | Industrials | 20.28% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Financials | 5.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
51
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16.5M | 0.74% |
+226,282
| New | +$12M |
|
|
LOVE
52
LoveSac
LOVE
$253M
| $16.4M | 0.74% |
626,022
+492,370
| +368% | +$7.49M |
|
|
KRTX
53
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $16.2M | 0.73% |
145,257
+18,414
| +15% | +$1.6M |
|
54
Lattice Semiconductor
LSCC
$18.2B
| $16M | 0.72% |
+562,399
| New | +$13.1M |
|
55
RH
RH
$3.47B
| $15.5M | 0.69% |
+62,116
| New | +$11.3M |
|
56
Knight Transportation
KNX
$11.2B
| $15.5M | 0.69% |
370,600
-324,948
| -47% | -$12.4M |
|
57
Planet Fitness
PLNT
$3.7B
| $15.4M | 0.69% |
+254,861
| New | +$15.3M |
|
|
DCPH
58
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $15.3M | 0.69% |
+257,031
| New | +$13.7M |
|
|
TSC
59
DELISTED
TriState Capital Holdings, Inc.
TSC
| $15.2M | 0.68% |
968,359
-40,367
| -4% | -$549K |
|
60
Iovance Biotherapeutics
IOVA
$2.9B
| $15M | 0.67% |
+547,312
| New | +$18M |
|
61
Acadia Pharmaceuticals
ACAD
$5.06B
| $14.6M | 0.66% |
301,536
-288,828
| -49% | -$13.9M |
|
|
FRG
62
DELISTED
Franchise Group, Inc.
FRG
| $14.4M | 0.65% |
+660,000
| New | +$10.5M |
|
63
Trex
TREX
$4.91B
| $14.2M | 0.64% |
+218,710
| New | +$11.7M |
|
|
XLRN
64
DELISTED
Acceleron Pharma
XLRN
| $13.6M | 0.61% |
142,937
+33,273
| +30% | +$3.21M |
|
65
Cerus
CERS
$508M
| $13.1M | 0.59% |
+1,982,840
| New | +$11.4M |
|
66
Kornit Digital
KRNT
$778M
| $13.1M | 0.59% |
244,638
-177,868
| -42% | -$6.78M |
|
|
MDLA
67
DELISTED
Medallia, Inc.
MDLA
| $12.9M | 0.58% |
510,043
+135,316
| +36% | +$3.23M |
|
68
Agios Pharmaceuticals
AGIO
$1.95B
| $12.6M | 0.56% |
234,850
+112
| +0% | +$5.19K |
|
|
69
Cogent Communications
CCOI
$528M
| $12.5M | 0.56% |
161,984
-406,052
| -71% | -$32.9M |
|
|
RETA
70
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.3M | 0.55% |
+78,900
| New | +$12M |
|
|
GLUU
71
DELISTED
Glu Mobile Inc.
GLUU
| $12.2M | 0.55% |
1,318,870
-273,774
| -17% | -$2.33M |
|
72
CONMED
CNMD
$1.48B
| $12.1M | 0.54% |
+167,611
| New | +$11.7M |
|
73
Coherus Oncology
CHRS
$192M
| $11.9M | 0.53% |
667,028
-69,527
| -9% | -$1.18M |
|
74
Enphase Energy
ENPH
$5.41B
| $11.9M | 0.53% |
249,849
+57,207
| +30% | +$2.73M |
|
|
NOVA
75
DELISTED
Sunnova Energy
NOVA
| $11.7M | 0.53% |
+688,299
| New | +$9.75M |
|
Similar funds
RI
HI
MF
RA
GI
ACA
MPI
URS
Hood River Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Hood River Capital Management held 136 positions worth $2.23B, up 27% from $1.75B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Hood River Capital Management withdrew a net $113M in Q2 2020, closing 35 positions and reducing 39 holdings. Its most notable exit was Teladoc Health, an estimated $76.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
Against the trend, Hood River Capital Management opened a new position in Talend S.A. American Depositary Shares worth $35.8M.
- Hood River Capital Management's largest Q2 2020 buy was Talend S.A. American Depositary Shares: 1,032,808 shares worth $35.8M.
- Hood River Capital Management added most to Caesars Entertainment in Q2 2020, an estimated $34M increase.
- Hood River Capital Management's biggest Q2 2020 reduction was Kinsale Capital Group, cutting an estimated $39.1M.
- Hood River Capital Management fully exited Teladoc Health in Q2 2020, selling an estimated $76.6M.
- Hood River Capital Management's ten largest holdings make up 28% of its $2.23B portfolio in Q2 2020.
- Hood River Capital Management opened 38 new positions and closed 35 in Q2 2020.
- Hood River Capital Management's portfolio value rose 27% quarter-over-quarter to $2.23B.
Based on Hood River Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.